Derek Coombs

530 total citations
12 papers, 411 citations indexed

About

Derek Coombs is a scholar working on Rheumatology, Health, Toxicology and Mutagenesis and Hematology. According to data from OpenAlex, Derek Coombs has authored 12 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Health, Toxicology and Mutagenesis and 3 papers in Hematology. Recurrent topics in Derek Coombs's work include Spondyloarthritis Studies and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Derek Coombs is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Derek Coombs collaborates with scholars based in United States, Germany and United Kingdom. Derek Coombs's co-authors include Colin Hardy, Janette R. Cushman, Larry S. Andrews, George Cruzan, W. Ray Brown, Joanne D. Kilgour, Neil F. Johnson, Anna Karlsson, Christopher J. Collins and Graham Healey and has published in prestigious journals such as Food and Chemical Toxicology, Toxicological Sciences and Toxicology.

In The Last Decade

Derek Coombs

11 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek Coombs United States	7	126	123	111	67	44	12	411
Eian D. Massey United Kingdom	8	157 1.2×	185 1.5×	67 0.6×	131 2.0×	93 2.1×	13	478
James J. Freeman United States	14	140 1.1×	152 1.2×	33 0.3×	113 1.7×	28 0.6×	27	521
Joseph A. Cichocki United States	13	90 0.7×	87 0.7×	38 0.3×	104 1.6×	50 1.1×	23	398
Christian Pütz Germany	9	146 1.2×	179 1.5×	37 0.3×	63 0.9×	22 0.5×	15	353
Mostafa M. Elshafey Egypt	10	160 1.3×	61 0.5×	39 0.4×	179 2.7×	32 0.7×	14	450
William H. Steinhagen United States	17	209 1.7×	238 1.9×	62 0.6×	68 1.0×	25 0.6×	20	483
Michela Ballardin Italy	13	325 2.6×	150 1.2×	58 0.5×	192 2.9×	25 0.6×	17	629
E. E. McConnell United States	10	221 1.8×	160 1.3×	73 0.7×	103 1.5×	23 0.5×	15	514
U. Plappert Germany	12	305 2.4×	164 1.3×	50 0.5×	163 2.4×	28 0.6×	16	592
H.R. Immel Netherlands	9	105 0.8×	121 1.0×	43 0.4×	56 0.8×	22 0.5×	14	319

Countries citing papers authored by Derek Coombs

Since Specialization

Citations

This map shows the geographic impact of Derek Coombs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Coombs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Coombs more than expected).

Fields of papers citing papers by Derek Coombs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Coombs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Coombs. The network helps show where Derek Coombs may publish in the future.

Co-authorship network of co-authors of Derek Coombs

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Coombs. A scholar is included among the top collaborators of Derek Coombs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Coombs. Derek Coombs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Coates, Laura C., Ricardo Blanco, Frank Behrens, et al.. (2025). Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies. RMD Open. 11(3). e005522–e005522.

Charles‐Schoeman, Christina, Jon T. Giles, Nancy E. Lane, et al.. (2024). Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatology and Therapy. 11(1). 157–175. 5 indexed citations

Poddubnyy, Denis, Dirk Elewaut, Victoria Navarro‐Compán, et al.. (2024). Development of Extramusculoskeletal Manifestations in Upadacitinib‐Treated Patients With Psoriatic Arthritis or Axial Spondyloarthritis. Arthritis & Rheumatology. 77(5). 536–546. 2 indexed citations

Burmester, Gerd R, Andrea Rubbert‐Roth, Valderílio Feijó Azevedo, et al.. (2024). Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatology and Therapy. 11(3). 737–753. 6 indexed citations

Rubbert‐Roth, Andrea, Adriana María Kakehasi, Tsutomu Takeuchi, et al.. (2023). Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. Rheumatology and Therapy. 11(1). 97–112. 16 indexed citations

Alexander, David J., Christopher J. Collins, Derek Coombs, et al.. (2008). Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals. Inhalation Toxicology. 20(13). 1179–1189. 162 indexed citations

Cruzan, George, Janette R. Cushman, Larry S. Andrews, et al.. (2001). Chronic toxicity/oncogenicity study of styrene in cd‐1 mice by inhalation exposure for 104 weeks. Journal of Applied Toxicology. 21(3). 185–198. 107 indexed citations

Cruzan, George, Janette R. Cushman, Larry S. Andrews, et al.. (1998). Chronic Toxicity/Oncogenicity Study of Styrene in CD Rats by Inhalation Exposure for 104 Weeks. Toxicological Sciences. 46(2). 266–281. 87 indexed citations

Schroeder, Raymond E., et al.. (1996). Inhalation Teratology and Reproduction Studies with 1, 1-Dichloro-2,2,2-Trifluoroethane(HCFC-123). Toxicological Sciences. 34(2). 276–287. 9 indexed citations

10.

Coombs, Derek, et al.. (1995). Inhalation teratology and two-generation reproduction studies with 1,1-dichloro-1-fluoroethane (HCFC-141 b). Food and Chemical Toxicology. 33(4). 285–300. 7 indexed citations

11.

Chanter, D. O., et al.. (1987). The changes of false negative results in conventional toxicology studies with rats. Toxicology. 43(1). 65–74. 3 indexed citations

12.

Kesterson, J. W., et al.. (1979). Comparative Effects of Repeated and Prolonged Inhalation Exposure of Beagle Dogs and Cynomolgus Monkeys to Anaesthetic and Subanaesthetic Concentrations of Enflurane and Halothane. Acta Anaesthesiologica Scandinavica. 23(s71). 1–11. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact